While 100% of control mice developed ovarian metastases and died of disease by day 64, two out of the seven mice in the shCD105-2 group (most effective CD105 knockdown) were free of ovarian cancer metastases 4 months after cell injection. Here, ENG is linked to ovarian carcinoma.